首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Mechanical strain of glomerular mesangial cells in the pathogenesis of glomerulosclerosis: clinical implications (editorial)
【24h】

Mechanical strain of glomerular mesangial cells in the pathogenesis of glomerulosclerosis: clinical implications (editorial)

机译:肾小球系膜细胞的机械应变在肾小球硬化症发病中的作用:临床意义(编辑)

获取原文
获取原文并翻译 | 示例
           

摘要

Due to their elasticity, glomeruli will undergo excessive expansion and repetitive cycles of distension contraction under conditions of impaired glomerular pressure autoregulation and systemic arterial hypertension. These alterations in glomerular volume are associated with mesangial cell stretch which in turn stimulates the synthesis and deposition of ECM with eventual mesangial expansion and glomerulosclerosis. Hyperactivity of growth factors with prosclerotic activity is an important component in the translation of cellular mechanical strain into the abnormal metabolism of ECM components. Although mesangial cell mechanical strain is expected to occur in both remnant glomeruli and in glomeruli of diabetic kidneys, quantitatively different factors will determine the resultant metabolic consequences. In remnant glomeruli, the mechanical stretch is intense, being accounted for largely by the marked glomerular hypertrophy and increased glomerular compliance. In diabetic glomeruli, however, the mechanical stretch is less prominent but its effect on ECM synthesis is markedly aggravated by the presence of hyperglycaemia. There are presently no methods clinically available to diminish the prosclerotic action of growth factors at the glomerular level. In addition, there are no effective means to specifically improve glomerular pressure autoregulation. Therefore, current therapies must be aimed at decreasing systemic arterial pressure, blocking angiotensin II action and reducing glomerular hypertrophy. While there are effective drugs for the treatment of hypertension and for angiotensin II inhibition, protein restriction is the only measure available to diminish glomerular hypertrophy. Finally, in diabetes correction of systemic and glomerular hypertension should be coupled with strict glycaemic control to correct both glomerular autoregulation and increased ECM deposition.
机译:由于它们的弹性,在肾小球压力自动调节和全身性动脉高压受损的情况下,肾小球会经历过度的扩张和扩张收缩的重复循环。肾小球体积的这些改变与肾小球膜细胞伸展有关,继而刺激了ECM的合成和沉积,最终导致肾小球膜扩张和肾小球硬化。具有促硬化活性的生长因子过度活跃是细胞机械应变转化为ECM成分异常代谢的重要组成部分。尽管预期肾小球肾小球和糖尿病肾小球均会出现肾小球系膜细胞机械应变,但定量上不同的因素将决定最终的代谢后果。在残余的肾小球中,机械牵张很激烈,这在很大程度上是由明显的肾小球肥大和肾小球顺应性增加引起的。然而,在糖尿病性肾小球中,机械性伸展并不明显,但是高血糖症的存在会显着加重其对ECM合成的影响。目前尚无临床上可用于在肾小球水平降低生长因子的促硬化作用的方法。另外,还没有有效的手段来具体改善肾小球压力的自动调节。因此,当前的治疗必须针对降低全身动脉压,阻断血管紧张素II的作用和减少肾小球肥大。尽管有治疗高血压和抑制血管紧张素II的有效药物,但限制蛋白质的使用是减少肾小球肥大的唯一有效措施。最后,在糖尿病患者中,系统性和肾小球性高血压的纠正应与严格的血糖控制相结合,以纠正肾小球的自动调节和增加的ECM沉积。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号